reference/27725420

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27725420

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	14086
issn	2470-1343
issueIdentifier	10
pageRange	14076-14086
publicationName	ACS Omega
startingPage	14076
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d080875b5675136a84c73c0c8be85745 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2de62851aee5825eefb200d2346ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274de0cd095daad44a563971b32f4582
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f3d7f1d00ddfd1686ab40016e376aa6d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d0300227699686400048de8a20cbf1f1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5547c0b4577c7cb4df7329d470cd15c5
bibliographicCitation	Kodani SD, Wan D, Wagner KM, Hwang SH, Morisseau C, Hammock BD. Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega. 2018 Oct 31;3(10):14076–86. PMID: 30411058; PMCID: PMC6210075.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83fbbf020f1f4ab67e2f53914fd254ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25adcdf087132b996c79e712494c6790 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86e11e720aafb4542c106241e5324aab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9da2139b0beb15d57da9619dd93391d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1408-8317 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9204-7620
date	2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1021/acsomega.8b01625 https://pubmed.ncbi.nlm.nih.gov/PMC6210075 https://pubmed.ncbi.nlm.nih.gov/30411058
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/45691 https://portal.issn.org/resource/ISSN/2470-1343
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.3.2.10 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8641 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25154868 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73a11fcc483544a111d625220cabf099 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0b869ad16ce197d4bea1a7444d3d9cd0 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.99

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID381118834 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13850 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178101928 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2053 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14073 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2166 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID65030

Total number of triples: 46.